Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smart patch replace a pill for temperature monitoring?

NCT ID NCT07397988

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study with 12 adults checks if wearable temperature sensors can collect reliable data when compared to an ingestible capsule that measures core body temperature. Participants wear the sensors and swallow the capsule for about 48 hours. The goal is to see if the process works smoothly and the data stays accurate—no treatment or diagnosis is involved.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult participants (≥18 years) capable of providing informed consent and willing to comply with the project procedures, including ingestion of the capsule and continuous wearing of two wearable devices for around 48 hours until capsule excretion under free-living conditions.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written informed consent obtained prior to any project-specific procedures. * Age 18 years or older at enrolment. * Able and willing to comply with project procedures, including capsule ingestion, continuous wearable use for around 48 hours, and adherence to study instructions. * Able to swallow the ingestible temperature capsule without difficulty. * No contraindication to ingestible thermometry as assessed by the investigator. Exclusion Criteria: General: * Body weight \< 36 kg. * Women who are pregnant. * Participation in another clinical investigation involving an investigational medicinal product or medical device within the 30 days preceding enrolment or previous enrolment in the current project. * Enrolment of the Principal Investigator, project staff, their family members, employees, or other dependent persons. * Inability to provide valid informed consent or significant language barrier preventing adequate understanding of procedures. Implants \& MRI: * Presence of any active Implantable Medical Device (AIMD), including Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Deep Brain Stimulation (DBS) devices, or Left Ventricular Assist Devices (LVADs). * Requirement for MRI scanning during the seven days following the capsule intake. Cognitive/Physical Status: * Unconscious patients (prior to ingestion). * Patients with special needs or disabilities preventing safe autonomous swallowing. Gastrointestinal: * Known history of dysphagia or gag reflex troubles. * Previous gastrointestinal surgery resulting in bowel stenosis. * Current or planned surgical procedures on the GI tract (esophagus, stomach, intestines). * Zenker's diverticulum or felinization of the esophagus. * Risk or history of intestinal obstruction, strictures, or diverticula. * Hypomotility disorders (e.g., ileus). * Inflammatory Bowel Diseases including Crohn's disease or Ulcerative Colitis. Dermatological Exclusions (Rheo Vital+ Performance) * Dermatological conditions, wounds, tattoos, oedema, inflammation, active venous access, or other impairments at the medial upper arm or axillary region that could interfere with correct placement or functioning of the wearable device. * Excessive hair or concurrent devices that hinder correct sensor placement. * Known allergy to plastics or latex. Temperature Management: * Active external heating or cooling (e.g., cooling blankets). * Note: Use of pharmacological antipyretics (oral/IV) is permitted. Further Medical Conditions: * Currently existing acute back pain. * Symptomatic herniated disc.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Temperature change, body are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Body Temperature Changes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital Basel

    Basel, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.